Apellis Pharmaceuticals, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| WELLINGTON MANAGEMENT GROUP LLP | 11/14/2024 | 15.57 M | $448.95 M | -5.01% | 12.56% |
| ECOR1 CAPITAL, LLC | 11/14/2024 | 11.89 M | $342.93 M | 2.44% | 9.60% |
| AVORO CAPITAL ADVISORS LLC | 11/14/2024 | 11.11 M | $320.44 M | 0.00% | 8.97% |
| VANGUARD GROUP INC | 11/13/2024 | 9.82 M | $283.08 M | 0.06% | 7.92% |
| BLACKROCK FUNDING, INC. /DE | 11/13/2024 | 6.19 M | $178.59 M | 100.00% | 5.00% |
| DEEP TRACK CAPITAL, LP | 11/14/2024 | 4.40 M | $126.91 M | 76.03% | 3.55% |
| STATE STREET CORP | 11/14/2024 | 4.04 M | $116.54 M | -2.55% | 3.26% |
| JPMORGAN CHASE & CO | 12/26/2024 | 3.88 M | $112.04 M | 22.26% | 3.14% |
| MORGAN STANLEY | 11/14/2024 | 3.39 M | $97.76 M | 59.98% | 2.74% |
| BRAIDWELL LP | 11/14/2024 | 3.13 M | $90.13 M | 410.82% | 2.52% |
| OCTAGON CAPITAL ADVISORS LP | 11/14/2024 | 3.01 M | $86.72 M | 4.38% | 2.43% |
| T. ROWE PRICE INVESTMENT MANAGEMENT, INC. | 11/14/2024 | 2.99 M | $86.10 M | -26.26% | 2.41% |
| FMR LLC | 11/13/2024 | 2.90 M | $83.64 M | -12.11% | 2.34% |
| SIREN, L.L.C. | 11/13/2024 | 2.17 M | $62.50 B | 100.00% | 1.75% |
| ASSENAGON ASSET MANAGEMENT S.A. | 10/23/2024 | 2.14 M | $61.84 M | 191.87% | 1.73% |
| JENNISON ASSOCIATES LLC | 11/08/2024 | 1.82 M | $52.52 M | -49.29% | 1.47% |
| GEODE CAPITAL MANAGEMENT, LLC | 11/12/2024 | 1.81 M | $52.23 M | 1.26% | 1.46% |
| BOXER CAPITAL, LLC | 11/14/2024 | 1.73 M | $49.78 M | 0.00% | 1.39% |
| FIERA CAPITAL CORP | 11/01/2024 | 1.35 M | $39.06 M | -3.33% | 1.09% |
| ORBIMED ADVISORS LLC | 11/14/2024 | 1.27 M | $36.64 M | -2.49% | 1.03% |
| POLAR CAPITAL HOLDINGS PLC | 11/14/2024 | 1.08 M | $31.20 M | 0.24% | 0.87% |
| LOGOS GLOBAL MANAGEMENT LP | 11/14/2024 | 1.00 M | $28.84 M | -50.00% | 0.81% |
| BANK OF AMERICA CORP /DE/ | 11/14/2024 | 975,004 | $28.12 M | -2.02% | 0.79% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 11/12/2024 | 956,362 | $27.58 M | 0.99% | 0.77% |
| AMERIPRISE FINANCIAL INC | 11/14/2024 | 860,294 | $24.81 M | 9.74% | 0.69% |
| AQR CAPITAL MANAGEMENT LLC | 11/14/2024 | 817,260 | $23.57 M | 231.04% | 0.66% |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC | 11/14/2024 | 814,564 | $23.49 M | 18.21% | 0.66% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 11/14/2024 | 787,500 | $22.71 M | -23.45% | 0.64% |
| CANDRIAM S.C.A. | 11/13/2024 | 680,058 | $19.61 M | 25.23% | 0.55% |
| INVESCO LTD. | 11/12/2024 | 604,113 | $17.42 M | -45.22% | 0.49% |
| CAPTION MANAGEMENT, LLC | 11/14/2024 | 590,000 | $17.02 M | -41.28% | 0.48% |
| JANE STREET GROUP, LLC | 11/15/2024 | 481,000 | $13.87 M | 100.00% | 0.39% |
| VICTORY CAPITAL MANAGEMENT INC | 11/05/2024 | 411,906 | $11.88 M | -10.82% | 0.33% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 11/14/2024 | 378,456 | $10.92 M | -70.35% | 0.31% |
| NEW YORK STATE COMMON RETIREMENT FUND | 10/28/2024 | 376,613 | $10.86 M | -12.64% | 0.30% |
| RENAISSANCE TECHNOLOGIES LLC | 11/13/2024 | 372,331 | $10.74 M | 100.00% | 0.30% |
| RHENMAN & PARTNERS ASSET MANAGEMENT AB | 11/13/2024 | 367,500 | $10.60 M | 563.42% | 0.30% |
| BANK OF NEW YORK MELLON CORP | 11/12/2024 | 343,739 | $9.91 M | -0.42% | 0.28% |
| NUVEEN ASSET MANAGEMENT, LLC | 11/14/2024 | 340,723 | $9.83 M | 21.69% | 0.28% |
| UBS GROUP AG | 11/14/2024 | 314,684 | $9.08 M | 15.52% | 0.25% |
| PICTET ASSET MANAGEMENT HOLDING SA | 11/12/2024 | 297,953 | $8.77 M | 17.75% | 0.24% |
| JANE STREET GROUP, LLC | 11/15/2024 | 273,400 | $7.88 M | 100.00% | 0.22% |
| TWINBEECH CAPITAL LP | 11/14/2024 | 272,252 | $7.85 M | 368.82% | 0.22% |
| HUDSON BAY CAPITAL MANAGEMENT LP | 11/13/2024 | 260,000 | $7.50 M | 126.09% | 0.21% |
| BARCLAYS PLC | 11/19/2024 | 255,897 | $7.38 M | 17.99% | 0.21% |
| CAPITAL FUND MANAGEMENT S.A. | 11/13/2024 | 243,234 | $7.01 M | 20.72% | 0.20% |
| TD ASSET MANAGEMENT INC | 11/01/2024 | 238,212 | $7.02 M | -23.61% | 0.19% |
| ABRDN PLC | 10/25/2024 | 236,724 | $6.83 M | 0.00% | 0.19% |
| FIDUCIARY TRUST CO | 11/14/2024 | 236,066 | $6.81 M | -1.76% | 0.19% |
| 683 CAPITAL MANAGEMENT, LLC | 11/14/2024 | 235,000 | $6.78 M | 26.34% | 0.19% |
Apellis Pharmaceuticals, Inc.institutional Ownership - FAQ's
During the previous two years, 336 institutional investors and hedge funds held shares of Apellis Pharmaceuticals, Inc.. The most heavily invested institutionals were:
WOLFF WIESE MAGANA LLC: 0
WELLINGTON MANAGEMENT GROUP LLP: 15.57 M
EcoR1 Capital, LLC: 11.89 M
Avoro Capital Advisors LLC: 11.11 M
VANGUARD GROUP INC: 9.82 M
BlackRock Funding, Inc. /DE: 6.19 M
94.49% of Apellis Pharmaceuticals, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 122.94 M shares in the last 24 months. This purchase volume represents approximately $3.65 B in transactions.